These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [DRUG THERAPY OF CIRCULATORY DISEASES]. TAKATSU T Naika; 1964 Mar; 13():465-79. PubMed ID: 14125381 [No Abstract] [Full Text] [Related]
26. HAEMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES. DOLLERY CT; HARINGTON M; HODGE JV Br Heart J; 1963 Sep; 25(5):670-6. PubMed ID: 14063015 [No Abstract] [Full Text] [Related]
27. Effects of guanethidine and methyldopa on a standardized test for renin responsiveness. Lowder SC; Liddle GW Ann Intern Med; 1975 Jun; 82(6):757-60. PubMed ID: 1138585 [TBL] [Abstract][Full Text] [Related]
28. Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine). Baum T; Shropshire AT; Varner LL J Pharmacol Exp Ther; 1972 Jul; 182(1):135-44. PubMed ID: 5041650 [No Abstract] [Full Text] [Related]
31. Guanethidine and methyldopa as therapeutic agents in hypertension. A comparative review. GOLDBERG LI; ZIMMERMAN AM Postgrad Med; 1963 Jun; 33():548-54. PubMed ID: 13948676 [No Abstract] [Full Text] [Related]
32. [METHYLDOPA AND DECARBOXYLASE INHIBITION]. OFFERHAUS L; MUEHLEN AC; DE VRIES LA Ned Tijdschr Geneeskd; 1964 May; 108():966-8. PubMed ID: 14168782 [No Abstract] [Full Text] [Related]
33. [PHARMACEUTICAL PROGRESS IN ANTIHYPERTENSIVE DRUGS ACTING ON THE SYMPATHETIC NERVOUS SYSTEM]. PE TL Ko Hsueh Tung Pao; 1964; 3():208-17. PubMed ID: 14141914 [No Abstract] [Full Text] [Related]
34. Urinary 5-hydroxyindoleacetic acid in cases of hypertension before and after therapy with guanethidine and methyldopa. Nath K; Agarwal SN; Mittal HS; Singh KN; Saxena S; Pant H J Indian Med Assoc; 1972 Apr; 58(7):242-5. PubMed ID: 4537955 [No Abstract] [Full Text] [Related]
35. Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats. Rankin GO; Watkins BE; Sawutz DG Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):130-40. PubMed ID: 7165417 [TBL] [Abstract][Full Text] [Related]
36. TREATMENT OF HYPERTENSION WITH METHYLDOPA ALONE OR COMBINED WITH DIURETICS AND OR GUANETHIDINE. A REPORT OF 63 CASES. LEONARD JW; GIFFORD RW; HUMPHREY DC Am Heart J; 1965 May; 69():610-8. PubMed ID: 14280101 [No Abstract] [Full Text] [Related]
37. ANTAGONISM OF RESERPINE-INDUCED SUBSENSITIVITY TO TYRAMINE BY METHYLDOPA. VARMA DR; BENFEY BG J Pharmacol Exp Ther; 1963 Sep; 141():310-3. PubMed ID: 14064192 [No Abstract] [Full Text] [Related]
38. Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension. Finnerty FA; Brogden RN Drugs; 1985 Jul; 30(1):22-31. PubMed ID: 3896742 [TBL] [Abstract][Full Text] [Related]
39. EFFECTS OF METHYLDOPA IN HYPERTENSION. IGLOE MC JAMA; 1964 Jul; 189():188-90. PubMed ID: 14149999 [No Abstract] [Full Text] [Related]
40. The treatment of hypertension by beta adrenergic blocking drugs. Prichard BN Angiologica; 1966; 3(5):318-29. PubMed ID: 4381049 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]